Clinical Trials
7 trialsNCT05768139 2026-06-04
PIKALO-1
Eli Lilly and Company
Phase 1/2 Recruiting
NCT04414540 2026-05-08
Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients
University of Cincinnati
Phase 2 Active not recruiting
NCT04114136 2026-04-24
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
University of Pittsburgh
Phase 2 Recruiting
NCT03618654 2025-05-15
Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT02949700 2023-06-29
Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma
Baylor College of Medicine
Phase 1/2 Completed
NCT03510390 2021-11-18
HEAD-MET
Insel Gruppe AG, University Hospital Bern
Phase NA Completed
NCT02402348 2017-02-08
Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis
West Virginia University
Phase EARLY_PHASE1 Terminated